Gallamine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gallamine triethiodide (Flaxedil) is a non-depolarising muscle relaxant.[1] It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine.[2] Gallamine triethiodide has a parasympatholytic effect on the cardiac vagus nerve which causes tachycardia[3][4] and occasionally hypertension. Very high doses cause histamine release.
Gallamine triethiodide is commonly used to stabilize muscle contractions during surgical procedures.
It was developed by Daniel Bovet in 1947.[5]
The pharmaceutical is no longer marketed in the United States, according to the FDA Orange Book.
References
- ↑ “Webster’s Online Dictionary – Flaxedil”. Retrieved 2008-12-15.
- ↑ “RxMed: Pharmaceutical Information – FLAXEDIL”. Retrieved 2008-12-15.
- ↑ Morgenstern C, Splith G (October 1965). “[Studies on the causes of gallamine tachycardia and its antagonistic modification by beta adrenolytics]”. Der Anaesthesist (in German). 14 (10): 298–301. PMID 4380161.
|access-date=requires|url=(help) - ↑ WALTS LF (1963). “Ventricular tachycardia with gallamine and cyclopropane anesthesia”. Anesthesiology. 24: 119. doi:10.1097/00000542-196301000-00024. PMID 13998750. Retrieved 2014-09-20.
- ↑ Raghavendra T (July 2002). “Neuromuscular blocking drugs: discovery and development”. J R Soc Med. 95 (7): 363–7. doi:10.1258/jrsm.95.7.363. PMC 1279945. PMID 12091515.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH